Leading expert in pharmacoepidemiology and drug safety, Dr. Stephen Evans, MD, explains clinical trial analysis and medication safety monitoring. He addresses major vaccine safety concerns and scientific fraud detection. Dr. Evans contributes to global health through WHO and European Medicines Agency committees. His work spans decades of medical statistics and pharmacoepidemiology research.
More from DiagnosticDetectives.Com
Clinical Trials Analysis and Medication Safety Monitoring Expertise
Jump To Section
- Pharmacoepidemiology Expertise
- Clinical Trials Analysis
- Vaccine Safety Investigations
- Medication Safety Issues
- Professional Leadership Roles
- Scientific Fraud Detection
- Full Transcript
Pharmacoepidemiology Expertise
Dr. Stephen Evans, MD, brings extensive expertise in pharmacoepidemiology to medication safety research. He serves as Professor of Pharmacoepidemiology at The London School of Hygiene & Tropical Medicine. Dr. Evans specializes in studying the safety of medicines, vaccines, and surgical treatments. His background includes physics, chemistry, and computing before transitioning to medical statistics.
Clinical Trials Analysis
Clinical trials analysis forms a core component of Dr. Stephen Evans, MD' professional work. He obtained his Master of Science in Medical Statistics from LSHTM, providing strong foundation for clinical research. Dr. Evans spent 25 years at The London Hospital and Medical College, becoming Professor of Medical Statistics in 1990. His statistical expertise supports proper interpretation of clinical trial data and research outcomes.
Vaccine Safety Investigations
Vaccine safety investigations represent a significant area of Dr. Stephen Evans, MD' contributions to public health. He addressed the Measles Mumps Rubella vaccine and autism controversy during his tenure at the UK Medicines Control Agency. Dr. Evans also served on the WHO Global Advisory Committee on Vaccine Safety, providing global leadership. These roles demonstrate his commitment to evidence-based vaccine safety assessment.
Medication Safety Issues
Medication safety issues have been a focus throughout Dr. Stephen Evans, MD' distinguished career. He investigated Hormone Replacement Therapy and breast cancer risks during his regulatory work. Dr. Evans also examined vitamin K administration and childhood cancer concerns. His work at the European Medicines Agency Drug Safety Committee until 2018 further advanced medication safety monitoring.
Professional Leadership Roles
Professional leadership roles highlight Dr. Stephen Evans, MD' influence in the medical community. He served as President of the International Society of Pharmacoepidemiology, leading the field's premier organization. Dr. Evans contributes to numerous editorial boards including the British Journal of Clinical Pharmacology. His statistical advisory role for the British Medical Journal ensures research publication quality.
Scientific Fraud Detection
Scientific fraud detection represents another critical aspect of Dr. Stephen Evans, MD' expertise. He developed specialized skills in identifying research misconduct and data manipulation. Dr. Evans advised the Bristol Royal Infirmary Inquiry investigating child heart surgery deaths. His Honorary Fellowship with The Royal College of Physicians of London recognizes his contributions to medical science integrity.
Full Transcript
Hello from New York! We are with Professor Stephen Evans, who is in London. He is a Professor of Pharmacoepidemiology at The London School of Hygiene & Tropical Medicine. Professor Evans is a world-renowned expert in the study of safety of medicines, vaccines, and surgical and medical treatments.
He is an expert in the analysis of clinical trials and detection of scientific fraud and misconduct.
Professor Stephen Evans first trained in physics, chemistry and computing. He obtained a Master of Science in Medical Statistics at LSHTM and worked at The London Hospital and Medical College for 25 years, where he became a Professor of Medical Statistics in 1990.
Professor Stephen Evans was at the UK Medicines Control Agency, where he dealt with major medication and vaccine safety issues such as Hormone Replacement Therapy and breast cancer; vitamin K and childhood cancer; Measles Mumps Rubella vaccine and autism.
He was an advisor on the Bristol Royal Infirmary Inquiry, an investigation into a high number of child heart surgery deaths.
Professor Evans was until 2018 an independent expert for the European Medicines Agency Drug Safety Committee.
Professor Stephen Evans was a President of the International Society of Pharmacoepidemiology. Professor Evans is or has been on various editorial boards, including the British Journal of Clinical Pharmacology.
He has been a statistical advisor to the British Medical Journal.
Professor Evans was also a member of the WHO Global Advisory Committee on Vaccine Safety. He is an Honorary fellow of The Royal College of Physicians of London.
Dr. Anton Titov, MD: Professor Evans, hello and welcome!